Tuesday, June 30, 2009
at
11:40 AM
Posted by
kibowbiotech
Kibow has a recently published a paper on CMRO.
Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot
scale trial in Canada
Aim: This was a pilot clinical trial to assess biochemical and clinical effects of an oral probiotic dietary supplement in chronic kidney disease (CKD) patients (stages 3 and 4).
For the entire study paper, please visit:
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment